Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

Ozguroglu M., Evrensel T., Er O., TURNA Z. H., Yanmaz T., Yildiz O., ...More

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.225 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 17
  • City: İstanbul
  • Country: Turkey
  • Page Numbers: pp.225
  • Bursa Uludag University Affiliated: Yes